Results: 174

Efficacy of tacrolimus for induction of remission in patients with moderate-to-severe ulcerative colitis: a systematic review and meta-analysis

Arq. gastroenterol; 54 (2), 2017
ABSTRACT BACKGROUND There is evidence that shows that calcineurin inhibitors may be useful for the treatment of severe ulcerative colitis. However, evidence regarding the efficacy of tacrolimus for remission induction in this setting is scarce. OBJECTIVE To develop a systematic review on the existing...

Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial

Arq. bras. oftalmol; 80 (3), 2017
ABSTRACT Purpose: To assess the efficacy of monotherapy using tacrolimus eye drops versus sodium cromoglycate for the treatment of vernal keratoconjunctivitis (VKC). Methods: Randomized double-masked controlled trial comparing the efficacy of tacrolimus 0.03% eye drops t.i.d. (Group 1) with sodium crom...

Cut-off value for absolute lymphocytes as an alternative for the immunophenotypic analysis of CD3+ T cells in the monitoring of immunosuppressive therapy with thymoglobulin

J. bras. nefrol; 39 (2), 2017
Abstract Introduction: Immunosuppression of T lymphocytes is required for preventing acute rejection after transplantation and for the treatment of chronic autoimmune and inflammatory diseases. The laboratory monitoring for this therapy is the measurement of T cells by immunophenotyping, aiming the targ...

Belatacept in kidney transplantation - past and future perspectives

J. bras. nefrol; 39 (2), 2017
Abstract Calcineurin inhibitors (CNIs) are used widely for maintenance immunosuppression in renal transplant recipients. However, their side effect profile has led researchers to attempt to find safer alternatives that can maintain effective long-term immunosuppression with less toxicity. Belatacept is a...

Clinical course of Behcet's disease in a patient with delayed diagnosis and radiological follow-up of the thrombi with computed tomography angiography: a five-year follow-up under immunosuppressive treatment

Rev. bras. reumatol; 57 (3), 2017

Experiencia local con natalizumab en pacientes con enfermedad de Crohn refractaria a anti-TNF: casos clínicos

Rev. méd. Chile; 145 (4), 2017
Anti-tumor necrosis factor-α (TNF) agents have dramatically changed the management of Crohn’s Disease (CD). However, a significant number of these patients do not respond at all or cease to respond to antibodies against TNF. In this clinical situation, the options include intensification of anti-TN...

Acute Hepatitis E Mimicking a Flare of Disease in a Patient with Chronic Autoimmune Hepatitis

Ann. hepatol; 16 (1), 2017
Abstract: Acute hepatitis E is becoming increasingly recognised in Europe with up to 40% of the population in Southern France being exposed to the virus, which is harboured in pigs. Patients with known liver disease may present with acute hepatitis E and present a diagnostic challenge. For example patien...

Avaliação de terapias imunossupressoras em transplantes renais com uma abordagem metabolômica

O aprimoramento das técnicas analíticas viabilizou a metabolômica, uma área da ciência que busca compreender, de forma comparativa, os metabólitos envolvidos nas vias bioquímicas. A metabolômica está inserida no contexto das "ômicas", que teve início na "Era Genômica", a qual permitiu a ident...

Cuidado clínico de enfermagem fundamentado em Parse: contribuição no processo de transcendência de transplantados cardíacos

Rev. gaúch. enferm; 38 (2), 2017
RESUMO Objetivo Identificar como os cuidados clínicos e educativos de enfermagem, fundamentados na Teoria Human Becoming, contribuem para o processo de transcendência das pessoas transplantadas cardíacas na busca do bem viver. Método Pesquisa-intervenção desenvolvida com quatro transplantados c...

Hepatitis autoinmune refractaria: ¿cómo escoger el tratamiento de segunda línea o de rescate?

Gastroenterol. latinoam; 28 (2), 2017
Autoimmune hepatitis (AIH) is a liver disease of unknown etiology, with a breakdown in peripheral selftolerance against hepatocytes with both genetic and environmental factors involved. It is characterized by an immune mediated liver injury, with detectable autoantibodies, elevated levels of immunoglobul...